Stemline Therapeutics to Present at Leerink Swann and Company Global Healthcare Conference

[at noodls] – NEW YORK, Feb. 12, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) … more

View todays social media effects on STML

View the latest stocks trending across Twitter. Click to view dashboard

See who Stemline is hiring next, click here to view